(Presolicitation Notice) Intent to Sole Source - Biol Specimens for Lenacapavir PEP
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in ATLANTA, GA
- Industry: Medical Laboratories
- Advance notice of upcoming solicitation
Contract Details
- Notice ID
- PR97866
- Opportunity Type
- Presolicitation
- Sub-Agency
- CENTERS FOR DISEASE CONTROL AND PREVENTION
- Office
- CDC OFFICE OF ACQUISITION SERVICES
- Posted Date
- Thursday, September 3, 2026
- Response Deadline
- Thursday, September 17, 2026
- NAICS Code
- 621511 - Medical Laboratories
- PSC Code
- 6550
- Set-Aside
- No Set Aside
- Place of Performance
- ATLANTA, GA, 30333
- Status
- Active
Description
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Emory University for the procurement and delivery of biological specimens from persons receiving weekly oral lenacapavir. Emory maintains established HIV clinical-research infrastructure, including HIV prevention and treatment clinical-research capabilities, and has documented prior experience performing CDC-supported clinical studies involving extensive biological specimen collection and pharmacokinetic-related procedures. Emory also has prior CDC DHP contract performance and documented experience with the collection, processing, handling, and transfer of biological specimens required for CDC-supported research. This established experience provides continuity with CDC DHP labor
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for medical laboratories with a set-aside for No Set Aside businesses in ATLANTA, GA. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
